This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).

Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial / Adamo, Daniela; Pecoraro, Giuseppe; Coppola, Noemi; Calabria, Elena; Aria, Massimo; Mignogna, Michele Davide. - In: ORAL DISEASES. - ISSN 1354-523X. - 27:4(2021), pp. 1022-1041. [10.1111/odi.13602]

Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial

Coppola, Noemi;Calabria, Elena
;
Aria, Massimo;Mignogna, Michele Davide
2021

Abstract

This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).
2021
Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial / Adamo, Daniela; Pecoraro, Giuseppe; Coppola, Noemi; Calabria, Elena; Aria, Massimo; Mignogna, Michele Davide. - In: ORAL DISEASES. - ISSN 1354-523X. - 27:4(2021), pp. 1022-1041. [10.1111/odi.13602]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/817473
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 11
social impact